The test may be able to assess whether antibodies from infection or vaccination can fight a specific variant, or if a vaccine is effective against a variant.
Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System
Under the deal, DUHS will establish PGDx's next-generation sequencing-based Elio Tissue Complete platform for the genomic profiling of cancer in its lab.
NIH, CDC Launch Program to Provide Free Coronavirus Self-Testing
The program, which will provide supplies of rapid, at-home antigen tests, aims to determine if frequent self-testing can reduce community transmission of the virus.
In Fight Against Coronavirus, Developers Turn to Emerging, As Well As Established, Technologies
Emerging technologies included biosensors, host response tests using different types of biomarkers, and new ways to make and develop antigen, antibody, and PCR tests.
Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
Inflammatix said that if its test obtains Emergency Use Authorization next year, clinicians will be able to better gauge the severity of a COVID-19 patient's infection.